BDBM94503 cid_65494 MLS002320668 SUFENTANIL 2-hydroxypropane-1,2,3-tricarboxylic acid;N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)-4-piperidinyl]-N-phenylpropanamide N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenyl-propanamide;2-oxidanylpropane-1,2,3-tricarboxylic acid citric acid;N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]-N-phenyl-propionamide 2-hydroxypropane-1,2,3-tricarboxylic acid;N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide Sufentanil citrate SMR001338814 Sufentanyl
R-30730 Sufenta SufentanilN-[4-Methoxymethyl-1-(2-thiophen-2-yl-ethyl)-piperidin-4-yl]-N-phenyl-propionamide CHEMBL658 SUFENTANIL N-(4-(methoxymethyl)-1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropionamide N-[4-Methoxymethyl-1-(2-thiophen-2-yl-ethyl)-piperidin-4-yl]-N-phenyl-propionamide BDBM50012490
- Henriksen, G; Platzer, S; Hauser, A; Willoch, F; Berthele, A; Schwaiger, M; Wester, HJ 18F-labeled sufentanil for PET-imaging of mu-opioid receptors. Bioorg Med Chem Lett 15: 1773-7 (2005)
- Wandel, C; Kim, R; Wood, M; Wood, A Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology 96: 913-20 (2002)